Board of Directors

Caroline is a partner at EcoR1 Capital, where she invests in private and public biotechnology companies. In this capacity, she also served as chief investment officer of Panacea Acquisition Corporation I and II. Prior to EcoR1, Caroline was a healthcare investment banker at Credit Suisse. She received a B.A. in economics from Georgetown University.